Antonio R Pera insider trades
Open-market stock purchases and sales by Antonio R Pera, Director at ANI Pharmaceuticals Inc, from SEC Form 4 filings since Feb 21, 2017.
Track record: 100% of 1 scored buy are up 5% or more since purchase, averaging +80%.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| May 21, 2026 | ANIP ANI Pharmaceuticals Inc | Bought (not open market) | — |